NCT06246188View on ClinicalTrials.gov

Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Cardiac MRI using Regadenoson and GE-267

Performing stress-cardiac MRI for clinical diagnostic in adult patients with suspected coronary artery disease

Trial Locations (1)

13353

Deutsches Herzzentrum der Charité, Berlin

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

German Heart Institute

OTHER